Skip to content

Clinical trials

Completed Hyperlipidemias trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Completed Country / region: India Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20111
20121
20131
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.1
AstraZeneca1
Ionis Pharmaceuticals, Inc.1
Jamia Hamdard University1
NMP Medical Research Institute1
Olive Lifesciences Pvt Ltd1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
PreEmptive Meds, Pvt. Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias8
Dyslipidemias3
Hypertriglyceridemia3
Hypercholesterolemia2
Metabolic Diseases2
Cardiovascular Diseases1
Hypertension1
Lipid Metabolism Disorders1
Prediabetic State1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.